Ignite Creation Date:
2025-12-24 @ 7:03 PM
Ignite Modification Date:
2025-12-25 @ 4:36 PM
Study NCT ID:
NCT05270057
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-09
First Post:
2022-02-24
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Loncastuximab Tesirine in Combination With DA-EPOCH-R in Patients With Previously Untreated Aggressive B-cell Lymphoid Malignancies
Sponsor:
Medical College of Wisconsin
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-26
Start Date Type:
ACTUAL
Primary Completion Date:
2025-05-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2027-10-11
Completion Date Type:
ESTIMATED
First Submit Date:
2022-02-24
First Submit QC Date:
None
Study First Post Date:
2022-03-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-07
Last Update Post Date:
2025-10-09
Last Update Post Date Type:
ESTIMATED